Modifi Bio

Modifi Bio is an innovative biotechnology company dedicated to pioneering a novel oncology therapeutics platform. Focusing on DNA defects prevalent in various cancer cells, Modifi Bio is committed to transforming conventional oncology drug development. Their groundbreaking approach centers around modifying tumor DNA in a way that is irreparable to cancer cells while preserving the integrity of healthy cells.

Modifi Bio has engineered a new class of small molecules that directly target DNA, thereby bypassing the need to engage protein targets directly and exploiting tumor-associated DNA repair defects. This strategy, validated across numerous tumor types both in vitro and in vivo, reflects the company's commitment to improving patient outcomes. Located in the thriving biotech hub of New Haven, CT, Modifi Bio's state-of-the-art laboratories at the Elm City BioScience Center provide an ideal environment for innovation and growth.

Modifi Bio is poised to make significant strides in the fight against cancer through its unique therapeutic platform. Modifi Bio continues to develop and refine its technologies, with a focus on creating effective and targeted cancer treatments. We invite the management of Modifi Bio to create a customized and exclusive company showcase and product listing on our platform to further highlight their advancements and commercial potential.